Lafadofensine

Lafadofensine
Clinical data
Drug class	Serotonin–norepinephrine–dopamine reuptake inhibitor
Identifiers
	IUPAC name (3S)-N,N-bis(4-fluorophenyl)pyrrolidin-3-amine;
CAS Number	914989-90-5 ; 914989-91-6 (fumarate);
PubChem CID	15605612;
ChemSpider	13081085;
UNII	7HFV4D3KJL;
ChEMBL	ChEMBL5095070;
Chemical and physical data
Formula	C16H16F2N2
Molar mass	274.315 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES C1CNC[C@H]1N(C2=CC=C(C=C2)F)C3=CC=C(C=C3)F;
	InChI InChI=1S/C16H16F2N2/c17-12-1-5-14(6-2-12)20(16-9-10-19-11-16)15-7-3-13(18)4-8-15/h1-8,16,19H,9-11H2/t16-/m0/s1; Key:ZKEVVJGPWXTETN-INIZCTEOSA-N;

Lafadofensine (INNTooltip International Nonproprietary Name), also known as (3S)-N,N-bis(4-fluorophenyl)pyrrolidin-3-amine, is a drug described as an antidepressant which has not been marketed at this time.^[1]^[2]^[3] It is said to act as a serotonin–norepinephrine–dopamine reuptake inhibitor (SNDRI).^[1] The drug was first described by 2010^[4] and its INNTooltip International Nonproprietary Name was proposed by 2021.^[5]

References

^ ^a ^b World Health Organization (2024). "Use of stems in the selection of International Nonproprietary Names (INN) for pharmaceutical substances, 2024" (PDF). World Health Organization. p. 102. Retrieved 21 October 2024. -fensine norepinephrine, serotonin, dopamine reuptake inhibitors brasofensine (76), diclofensine (44), lafadofensine (126), liafensine (109), nomifensine (24), perafensine (44), tesofensine (89)
^ "LAFADOFENSINE". Inxight Drugs. Retrieved 21 October 2024.
^ "Lafadofensine". PubChem. Retrieved 21 October 2024.
^ AU 2006/244851B2, Akazawa K, Amada N, Ito N, Kurimura M, Masumoto T, Matsuzaki T, Menjo Y, Miyamura S, Morita C, Nakajima S, Ohashi S, Sakata Y, Sakurai Y, Sasaki H, Shinohara T, Sugino H, Tai K, Taira S, Takemura N, Tomoyasu T, Watanabe A, Yamashita J, "N,N-substituted 3-aminopyrrolidine compounds useful as monoamines reuptake inhibitors", issued 10 June 2010, assigned to Otsuka Pharmaceutical Co Ltd.
^ "Proposed INN: List 126 International Nonproprietary Names for Pharmaceutical Substances (INN)" (PDF). WHO Drug Information. 35 (4). 2021.

This psychoactive drug-related article is a stub. You can help Wikipedia by expanding it.

[WHO2024-1] World Health Organization (2024). "Use of stems in the selection of International Nonproprietary Names (INN) for pharmaceutical substances, 2024" (PDF). World Health Organization. p. 102. Retrieved 21 October 2024. -fensine norepinephrine, serotonin, dopamine reuptake inhibitors brasofensine (76), diclofensine (44), lafadofensine (126), liafensine (109), nomifensine (24), perafensine (44), tesofensine (89)

[InxightDrugs-2] "LAFADOFENSINE". Inxight Drugs. Retrieved 21 October 2024.

[PubChem-3] "Lafadofensine". PubChem. Retrieved 21 October 2024.

[AU2006244851B2-4] AU 2006/244851B2, Akazawa K, Amada N, Ito N, Kurimura M, Masumoto T, Matsuzaki T, Menjo Y, Miyamura S, Morita C, Nakajima S, Ohashi S, Sakata Y, Sakurai Y, Sasaki H, Shinohara T, Sugino H, Tai K, Taira S, Takemura N, Tomoyasu T, Watanabe A, Yamashita J, "N,N-substituted 3-aminopyrrolidine compounds useful as monoamines reuptake inhibitors", issued 10 June 2010, assigned to Otsuka Pharmaceutical Co Ltd.

[WHO2021-5] "Proposed INN: List 126 International Nonproprietary Names for Pharmaceutical Substances (INN)" (PDF). WHO Drug Information. 35 (4). 2021.

[1]

[2]

[3]

[4]

[5]

See also

References